Skip navigation
× You've used up your 3 free articles for this month. Subscribe today.

Study Shows Treating HCV in Prisons with Pegylated Interferon Is Cost-Effective

Study Shows Treating HCV in Prisons with Pegylated Interferon Is Cost-Effective

by Matt Clarke

A new study published in the November 2008 issue of the medical journal Hepatology found that treating hepatitis C-infected prisoners with the standard therapy of pegylated interferon and ribavirin was cost-effective. Savings were as high as ...

 

Full article and associated cases available to subscribers.

As a digital subscriber to Prison Legal News, you can access full text and downloads for this and other premium content.

Subscribe today

Already a subscriber? Login